Startups
Oxford PharmaGenesis is a HealthScience communications consultancy. We are the largest independently owned and financed company in the medical communications sector. Founded in 1998, our award-winning organization now comprises more than 500 talented people working from offices and homes worldwide. We are connected by a strong company culture and a clear mission: to help clients to bring new evidence-based treatments to the world in areas of unmet need. Contact us to find out how we apply powerful thinking, dedicated to your success.
Overview
Location
United States, Ohio, Oxford
Employees
501-1000
Founded date
1998
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 11, 2021 | Plain Language Results of DESTINY-Breast01 Clinical Study: CISCRP & OxfordPharmaGenesis Collaborate with Partners For Article in Future Oncology | The teams involved—Daiichi Sankyo, AstraZeneca, CISCRP, Oxford PharmaGenesis, and Dr. Modi —worked to ensure the PLSP was easy-to-read by adding creative visuals, tables and key questions answered about the DESTINY-Breast01 trial. BOSTON (P... |
| Feb 17, 2021 | Plain Language Summary Publication of Key Results from Bayer’s Phase 3 ARAMIS Trial Published in Future Oncology | "Clinical trials are life. Very simply, for us patients, clinical trials are our life force,” wrote Mr. Nowak, a patient author. “Clinical trials have become so advanced." BOSTON (PRWEB) February 17, 2021 The Center for Informatio... |
Reviews 0
FAQ about Oxford PharmaGenesis
When was Oxford PharmaGenesis founded?
Oxford PharmaGenesis was founded in 1998.
What has the press written about Oxford PharmaGenesis?
Parsers VC has collected 3 articles mentioning Oxford PharmaGenesis, among them “Plain Language Results of DESTINY-Breast01 Clinical Study: CISCRP & OxfordPharmaGenesis Collaborate with Partners For Article in Future Oncology” (Aug 11, 2021) and “Plain Language Summary Publication of Key Results from Bayer’s Phase 3 ARAMIS Trial Published in Future Oncology” (Feb 17, 2021).
Is Oxford PharmaGenesis still active?
Yes, Oxford PharmaGenesis is active; its latest activity on Parsers VC dates from Oct 14, 2026.